Login / Signup

Sense and nonsense concerning biotin interference in laboratory tests.

Alena MoermanJoris Richard Delanghe
Published in: Acta clinica Belgica (2020)
Solutions to overcome this interference are: informing patients prior to analysis (avoiding peak biotin values when sampling), choice of appropriate immunoassays, and use of biotin removing steps prior to analysis.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • decision making